Matthaiou, A.M.; Bizymi, N.; Pagonidis, K.; Manousaki, E.; Fragkoulakis, M.; Lambiri, I.; Mitrouska, I.; Vasarmidi, E.; Tzanakis, N.; Antoniou, K.M.
Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease. J. Pers. Med. 2024, 14, 161.
https://doi.org/10.3390/jpm14020161
AMA Style
Matthaiou AM, Bizymi N, Pagonidis K, Manousaki E, Fragkoulakis M, Lambiri I, Mitrouska I, Vasarmidi E, Tzanakis N, Antoniou KM.
Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease. Journal of Personalized Medicine. 2024; 14(2):161.
https://doi.org/10.3390/jpm14020161
Chicago/Turabian Style
Matthaiou, Andreas M., Nikoleta Bizymi, Konstantinos Pagonidis, Eirini Manousaki, Michail Fragkoulakis, Irini Lambiri, Ioanna Mitrouska, Eirini Vasarmidi, Nikolaos Tzanakis, and Katerina M. Antoniou.
2024. "Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease" Journal of Personalized Medicine 14, no. 2: 161.
https://doi.org/10.3390/jpm14020161
APA Style
Matthaiou, A. M., Bizymi, N., Pagonidis, K., Manousaki, E., Fragkoulakis, M., Lambiri, I., Mitrouska, I., Vasarmidi, E., Tzanakis, N., & Antoniou, K. M.
(2024). Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease. Journal of Personalized Medicine, 14(2), 161.
https://doi.org/10.3390/jpm14020161
